Lana Medical Co. posted SAR 12.5 million in net profit for 2024, against net losses of SAR 1.9 million a year earlier.
Item | 2023 | 2024 | Change |
---|---|---|---|
Revenues | 48.63 | 84.09 | 72.9 % |
Gross Income | 19.21 | 24.90 | 29.6 % |
Operating Income | (0.30) | 8.57 | 2916.0 % |
Net Income | (1.93) | 12.46 | 746.9 % |
Average Shares | 5.40 | 5.40 | - |
Earnings Per Share before unusual items (Riyals) | (0.36) | 1.46 | 508.7 % |
EPS (Riyal) | (0.36) | 2.31 | 746.9 % |
The annual profit rise was driven by the company’s expanded market share, with government projects playing a pivotal role in sales growth.
Lana also witnessed a significant hike in the environment segment's revenues and medical supplies sales, including sales from National Unified Procurement Co. (nupco).
This is in addition to the commencement of commercial activities of the company's subsidiaries.
However, the 2024 profit growth was capped by the increased general & administrative expenses and financing costs.
Item | H2 2023 | H2 2024 | Change |
---|---|---|---|
Revenues | 26.96 | 50.42 | 87.0 % |
Gross Income | 11.12 | 13.61 | 22.3 % |
Operating Income | (4.14) | 6.50 | 257.0 % |
Net Income | (4.98) | 9.24 | 285.4 % |
Average Shares | 5.40 | 5.40 | - |
Earnings Per Share before unusual items (Riyal) | (0.92) | 0.86 | 193.3 % |
EPS (Riyal) | (0.92) | 1.71 | 285.4 % |
Item | H1 2024 | H2 2024 | Change |
---|---|---|---|
Revenues | 33.66 | 50.42 | 49.8 % |
Gross Income | 11.29 | 13.61 | 20.5 % |
Operating Income | 2.07 | 6.50 | 214.0 % |
Net Income | 1.07 | 9.24 | 766.9 % |
Average Shares | 5.40 | 5.40 | - |
Earnings Per Share before unusual items (Riyal) | 0.20 | 0.86 | 336.3 % |
EPS (Riyal) | 0.20 | 1.71 | 766.9 % |
In H2 2024, Lana generated a net profit of SAR 9.24 million, from a loss of SAR 4.98 million in H2 2023.
On a biannual basis, the six-month bottom line advanced by 186.9% from SAR 3.22 million.
Total shareholders’ equity, no minority interest, surged to SAR 61 million as of Dec. 31, 2024, compared to SAR 48.76 million a year earlier.
Be the first to comment
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments Analysis: